Barclays PLC Has $255,000 Stock Holdings in Atossa Therapeutics, …

Jan 6, 2025  · Barclays PLC grew its position in shares of Atossa Therapeutics, Inc. (NASDAQ:ATOS – Free Report) by 280.9% in the 3rd quarter, according to the company in its …


9%
OFF

Barclays PLC Has $255,000 Stock Holdings In Atossa Therapeutics, …

2 weeks from now

Jan 6, 2025  · Barclays PLC grew its position in shares of Atossa Therapeutics, Inc. (NASDAQ:ATOS – Free Report) by 280.9% in the 3rd quarter, according to the company in its …

defenseworld.net

9%
OFF

Barclays PLC Raises Stake In Atossa Therapeutics, Inc.

2 weeks from now

Jan 6, 2025  · Barclays PLC increased its stake in Atossa Therapeutics, Inc. (NASDAQ:ATOS – Free Report) by 280.9% during the third quarter, Holdings Channel.com reports. The …

americanbankingnews.com

9%
OFF

Atossa Therapeutics (NASDAQ:ATOS) Earns Buy Rating From HC …

2 weeks from now

Dec 14, 2024  · Barclays PLC raised its stake in Atossa Therapeutics by 280.9% during the 3rd quarter. Barclays PLC now owns 167,718 shares of the company’s stock valued at $255,000 …

etfdailynews.com

9%
OFF

Atossa Therapeutics, Inc. (NASDAQ:ATOS) Short Interest Update

2 weeks from now

Dec 16, 2024  · Atossa Therapeutics has a 1 year low of $0.70 and a 1 year high of $2.31. ... Barclays PLC increased its stake in Atossa Therapeutics by 280.9% during the 3rd quarter. …

marketbeat.com

$255000
OFF

Barclays PLC Acquires 7,879 Shares Of RGC Resources ... - Defense …

2 weeks from now

Jan 6, 2025  · Barclays PLC Has $255,000 Stock Holdings in Atossa Therapeutics, Inc. (NASDAQ:ATOS) Criteo S.A. (NASDAQ:CRTO) Shares Acquired by Barclays PLC; Barclays …

defenseworld.net

14%
OFF

BARCLAYS PLC Top 13F Holdings - WhaleWisdom.com

2 weeks from now

Sep 30, 2024  · Their last reported 13F filing for Q3 2024 included $376,798,956,000 in managed 13F securities and a top 10 holdings concentration of 41.14%. Barclays PLC's largest holding …

whalewisdom.com

$255000
OFF

ATOS Stock Price - Atossa Therapeutics Inc Stock Candlestick Chart

2 weeks from now

Atossa Therapeutics Inc (ATOS) Stock Price, Chart, Latest News, Technical Indicator, Option Chain and much more. Stock Screener App. Free - Install. ... Barclays PLC Has $255,000 …

stockscan.io

$255000
OFF

Barclays PLC Boosts Holdings In BRC Inc. (NYSE:BRCC)

2 weeks from now

Jan 6, 2025  · Barclays PLC Has $255,000 Stock Holdings in Atossa Therapeutics, Inc. (NASDAQ:ATOS) Criteo S.A. (NASDAQ:CRTO) Shares Acquired by Barclays PLC Barclays …

defenseworld.net

$79000
OFF

Barclays PLC Has $79,000 Stock Holdings In Karyopharm …

2 weeks from now

5 days ago  · The firm has a 50 day moving average price of $0.78 and a 200 day moving average price of $0.82. The stock has a market cap of $90.35 million, a P/E ratio of -0.63 and a beta of …

marketbeat.com

$255000
OFF

Barclays PLC Takes $255,000 Position In Bicara Therapeutics Inc ...

2 weeks from now

Jan 6, 2025  · Barclays PLC acquired a new position in Bicara Therapeutics Inc. (NASDAQ:BCAX – Free Report) during the third quarter, according to its most recent Form 13F filing with the …

tickerreport.com

$255000
OFF

Barclays PLC Raises Holdings In Orion Group Holdings, Inc.

2 weeks from now

Jan 6, 2025  · Barclays PLC Has $255,000 Stock Holdings in Atossa Therapeutics, Inc. (NASDAQ:ATOS) Criteo S.A. (NASDAQ:CRTO) Shares Acquired by Barclays PLC; Barclays …

defenseworld.net

$116000
OFF

Barclays PLC Has $116,000 Stock Holdings In Gyre Therapeutics, …

2 weeks from now

6 days ago  · Shares of GYRE stock opened at $9.62 on Thursday. The stock has a 50-day moving average of $12.20 and a 200-day moving average of $12.65. Gyre Therapeutics, Inc. …

etfdailynews.com

$264000
OFF

Barclays PLC Has $264,000 Stock Holdings In Rapport Therapeutics ...

2 weeks from now

Jan 6, 2025  · Rapport Therapeutics Stock Performance. NASDAQ RAPP opened at $19.48 on Monday. Rapport Therapeutics has a 12-month low of $16.55 and a 12-month high of $29.74. …

etfdailynews.com

1%
OFF

Barclays PLC Has $289,000 Stock Holdings In TScan Therapeutics, …

2 weeks from now

Jan 6, 2025  · Barclays PLC lifted its stake in shares of TScan Therapeutics, Inc. (NASDAQ:TCRX – Free Report) by 341.1% during the third quarter, Holdings Channel reports. The firm owned …

tickerreport.com

$258000
OFF

Barclays PLC Has $258,000 Holdings In BRT Apartments Corp.

2 weeks from now

Jan 6, 2025  · Barclays PLC Has $255,000 Stock Holdings in Atossa Therapeutics, Inc. (NASDAQ:ATOS) Criteo S.A. (NASDAQ:CRTO) Shares Acquired by Barclays PLC; Barclays …

defenseworld.net

$243000
OFF

Lantronix, Inc. (NASDAQ:LTRX) Stock Holdings Lifted By Barclays PLC

2 weeks from now

Jan 6, 2025  · Barclays PLC Has $243,000 Stock Position in Maui Land & Pineapple Company, Inc. (NYSE:MLP) Barclays PLC Has $255,000 Stock Holdings in Atossa Therapeutics, Inc. …

defenseworld.net

$255000
OFF

Caribou Biosciences, Inc. (NASDAQ:CRBU) Shares Purchased By …

2 weeks from now

Jan 6, 2025  · Barclays PLC Has $255,000 Stock Holdings in Atossa Therapeutics, Inc. (NASDAQ:ATOS) Criteo S.A. (NASDAQ:CRTO) Shares Acquired by Barclays PLC; Barclays …

defenseworld.net

6%
OFF

Barclays PLC Increases Holdings In Entrada Therapeutics

2 weeks from now

Jan 1, 2025  · Barclays PLC lifted its holdings in Entrada Therapeutics, Inc. (NASDAQ:TRDA - Free Report) by 210.6% in the third quarter, according to the company in its most recent 13F …

marketbeat.com


Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension